This inventor holds 1 USPTO granted patent. Top assignee: The University of Arizona. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Rifat Pamukeu: Innovator in Neoplasia Treatment
Introduction
Rifat Pamukeu is a notable inventor based in Spring House, PA (US). He has made significant contributions to the field of medical research, particularly in the treatment of neoplasia. His innovative work focuses on developing compounds that can effectively combat cancerous and precancerous lesions.
Latest Patents
Rifat Pamukeu holds a patent for "Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia." This patent describes compounds that are useful for inducing or promoting apoptosis and for arresting uncontrolled neoplastic cell proliferation. These compounds are specifically beneficial in the treatment and arresting of neoplasias, including both precancerous and cancerous lesions.
Career Highlights
Rifat Pamukeu is affiliated with the University of Arizona, where he continues to engage in groundbreaking research. His work has the potential to impact the medical community significantly, providing new avenues for cancer treatment.
Collaborations
Some of his notable coworkers include Gerhard J Sperl and Paul Gross. Their collaborative efforts contribute to the advancement of research in the field of neoplasia.
Conclusion
Rifat Pamukeu's innovative contributions to cancer treatment through his patented compounds highlight his role as a key figure in medical research. His work continues to inspire advancements in the fight against neoplastic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile